Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.21.1
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenue:    
Revenue
Other revenue 622  
Total revenue 622  
Operating expenses:    
Research and development, net of reimbursements 4,276 4,151
General and administrative 1,718 1,532
Total operating expenses 5,994 5,683
Loss from operations (5,372) (5,683)
Other income:    
Interest income - net 52 13
Total other income 52 13
Net loss $ (5,320) $ (5,670)
Net loss per share of common stock – basic and diluted (in Dollars per share) $ (0.29) $ (0.98)
Weighted average shares of common stock outstanding – basic and diluted (in Shares) 18,375,442 5,799,040